Significant Ownership of PERCEPTIVE ADVISORS LLC

Signature - Title
/s/ Joseph Edelman - Joseph Edelman, Managing Member
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by PERCEPTIVE ADVISORS LLC.

Follow Filing Activity

Follow PERCEPTIVE ADVISORS LLC and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Significant Ownership of PERCEPTIVE ADVISORS LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ADGM Adagio Medical Holdings, Inc. Common Stock, par value $0.0001 per share 58% $14,555,572 15,321,655 0% Perceptive Advisors LLC 31 Dec 2025
ATHA LeonaBio, Inc. Common Stock, $0.0001 par value 20% $13,052,440 -$68,291 1,859,322 -0.52% Perceptive Advisors LLC 16 Jan 2026
ATHA LeonaBio, Inc. Common Stock, $0.0001 par value 20% $715,301 1,882,370 Perceptive Advisors LLC 05 May 2026
LYRA Lyra Therapeutics, Inc. Common Stock, $0.001 par value 16% $22,174 255,750 Perceptive Advisors LLC 12 Aug 2025
SLDB Solid Biosciences Inc. Common Stock, $0.001 par value per share 13% $82,945,717 +$238,392 11,969,079 +0.29% Perceptive Advisors LLC 09 Mar 2026
MGTX MeiraGTx Holdings plc Ordinary Shares, nominal value $0.00003881 per share 13% $101,691,430 +$11,263,327 11,742,117 +12% Perceptive Advisors LLC 17 Apr 2026
NAUT Nautilus Biotechnology, Inc. Common Stock, $0.0001 par value per share 10% $11,149,148 +$192,185 12,815,113 +1.8% Perceptive Advisors LLC 20 Jun 2025
ANRO Alto Neuroscience, Inc. Common Stock, $0.0001 par value per share 10% $53,623,911 +$20,798,926 3,249,934 +63% Perceptive Advisors LLC 31 Dec 2025
ENGN enGene Holdings Inc. Common Shares 10% $47,123,411 6,770,605 Perceptive Advisors LLC 11 Nov 2025
IRD Opus Genetics, Inc. Common Stock, $0.0001 par value per share 10% $43,444,313 +$8,147,476 8,830,145 +23% Perceptive Advisors LLC 31 Mar 2026
PALI PALISADE BIO, INC. Common Stock, $0.01 par value 10% $29,184,225 +$5,677,630 15,200,117 +24% Perceptive Advisors LLC 31 Dec 2025
IKT INHIBIKASE THERAPEUTICS, INC. Common Stock, $0.001 par value 10% $25,633,286 12,816,643 Perceptive Advisors LLC 31 Dec 2025
OBIO Orchestra BioMed Holdings, Inc. Common Stock, par value $0.0001 per share 10% $14,085,110 5,679,480 Perceptive Advisors LLC 30 Sep 2025
RLAY KIORA PHARMACEUTICALS, INC. Common Stock, $0.01 par value 10% $4,362,830 -$89,215,124 438,471 -95% Perceptive Advisors LLC 06 Apr 2026
TRAW Traws Pharma, Inc. Common Stock, par value $0.01 per share 10% $1,641,628 +$632,468 886,887 +63% Perceptive Advisors LLC 30 Sep 2025
NVNO enVVeno Medical Corporation Common Stock, $0.00001 par value 10% $737,465 2,048,515 Perceptive Advisors LLC 31 Dec 2025
TRIB Trinity Biotech plc Class A Ordinary Shares, $0.0001 par value per share 9.9% $2,431,054,169 +$1,392,282,813 3,424,019,957 +134% Perceptive Advisors LLC 30 Apr 2026
OM Outset Medical, Inc. Common Stock, $0.001 par value per share 9.5% $32,688,000 5,625,000 Perceptive Advisors LLC 08 Jan 2025
TENX Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share 9.1% $8,568,085 +$1,958,998 569,308 +30% Perceptive Advisors LLC 31 Dec 2025
AMLX Amylyx Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 8.2% $121,662,640 +$14,650,251 8,952,365 +14% Perceptive Advisors LLC 30 Sep 2025
IVVD INVIVYD, INC. Common Stock, $0.0001 par value per share 7.9% $40,738,260 21,785,166 Perceptive Advisors LLC 18 Nov 2025
XFOR X4 PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share 7.6% $20,980,760 6,064,680 Perceptive Advisors LLC 27 Oct 2025
SABS SAB BIOTHERAPEUTICS, INC. Common Stock, $0.0001 par value per share 7.3% $13,088,916 3,471,861 Perceptive Advisors LLC 14 Jan 2026
PRAX Praxis Precision Medicines, Inc. Common Stock, par value $0.0001 per share 7.2% $575,742,162 +$182,728,171 1,995,986 +46% Perceptive Advisors LLC 31 Dec 2025
ALDX Aldeyra Therapeutics, Inc. Common Stock, par value $0.001 per share 7% $17,286,660 -$4,281,484 4,185,632 -20% Perceptive Advisors LLC 31 Dec 2025
CELC Celcuity Inc. Common Stock, $0.001 par value per share 6.8% $329,324,442 +$51,021,529 3,160,200 +18% Perceptive Advisors LLC 31 Dec 2025
RYTM Rhythm Pharmaceuticals, Inc. Common Stock, $0.001 par value per share 6.8% $284,913,835 4,423,441 Perceptive Advisors LLC 31 Mar 2025
OM Outset Medical, Inc. Common Stock, $0.001 par value per share 6.7% $14,028,758 1,208,334 Perceptive Advisors LLC 31 Mar 2025
EDSA EDESA BIOTECH, INC. Common Shares, without par value 6.7% $551,974 563,239 Perceptive Advisors LLC 09 Mar 2026
ZYME ZYMEWORKS INC. Common Stock, $0.00001 par value per share 5.4% $99,527,035 3,974,579 Perceptive Advisors LLC 08 Apr 2026
STRO SUTRO BIOPHARMA, INC. Common stock, $0.001 par value 5.4% $22,370,431 898,025 Perceptive Advisors LLC 14 Apr 2026
BDSX Biodesix, Inc. Common Stock, par value $0.001 per share 5.1% $4,374,112 +$570,000 7,673,880 +15% Perceptive Advisors LLC 12 May 2025
SYRE SPYRE THERAPEUTICS, INC. Common Stock, $0.0001 Par Value Per Share 5% $217,875,378 +$88,006,350 4,319,496 +68% Perceptive Advisors LLC 15 Apr 2026
IVA Inventiva S.A. Ordinary shares, nominal value euro 0.01 per share 5% $42,246,764 +$10,098,434 7,300,666 +31% Perceptive Advisors LLC 30 Sep 2025
TVTX TRAVERE THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 4.8% $124,537,820 -$17,973,533 4,278,180 -13% Perceptive Advisors LLC 31 Dec 2025
AVR Anteris Technologies Global Corp. Common Stock, par value $0.0001 per share 4.7% $5,933,852 -$2,557,348 1,705,130 -30% Perceptive Advisors LLC 30 Jun 2025
CTMX CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share 4.6% $43,424,943 +$1,800,148 10,098,824 +4.3% Perceptive Advisors LLC 31 Mar 2026
DRUG Bright Minds Biosciences Inc. Common Shares, without par value 4.6% $40,171,019 +$414,952 449,290 +1% Perceptive Advisors LLC 31 Dec 2025
ACLX Arcellx, Inc. Common Stock, par value $0.001 per share 4.5% $162,432,900 -$29,397,733 2,478,000 -15% Perceptive Advisors LLC 30 Jun 2025
RAPT RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share 4.5% $5,115,600 5,880,000 Perceptive Advisors LLC 31 Dec 2024
EWTX Edgewise Therapeutics, Inc. Common Stock, par value $0.0001 per share 4.4% $60,458,535 -$22,875,429 4,639,949 -27% Perceptive Advisors LLC 30 Jun 2025
AORT ARTIVION, INC. Common Stock, $0.01 par value 4.3% $85,526,800 2,020,000 Perceptive Advisors LLC 30 Sep 2025
IOVA Iovance Biotherapeutics, Inc. Common Stock, par value $0.000041666 per share 3.8% $45,599,285 -$33,120,382 12,808,788 -42% Perceptive Advisors LLC 31 Mar 2025
EOLS Evolus, Inc. Common Stock, $0.00001 par value per share 3.8% $23,461,512 -$15,682,755 2,474,843 -40% Perceptive Advisors LLC 30 Jun 2025
ENSC Ensysce Biosciences, Inc. Common Stock, par value $0.0001 per share 3.7% $264,331 86,666 0% Perceptive Advisors LLC 31 Mar 2025
BBNX Beta Bionics, Inc. Common Stock, $0.0001 par value per share 3.7% $21,609,324 1,593,608 Perceptive Advisors LLC 31 Mar 2025
CTNM Contineum Therapeutics, Inc. Class A Common Stock, par value $0.001 per share 3.2% $2,776,959 -$2,944,799 699,486 -51% Perceptive Advisors LLC 30 Jun 2025
CRGX CARGO Therapeutics, Inc. Common Stock, $0.001 par value per share 2.5% $5,420,850 1,170,810 Perceptive Advisors LLC 23 Apr 2025
FBRX Forte Biosciences, Inc. Common Stock, par value $0.001 per share 2.5% $1,209,840 163,935 Perceptive Advisors LLC 31 Dec 2024
FOLD Amicus Therapeutics, Inc. Common Stock, par value $0.01 per share 2.4% $43,290,927 -$82,061,910 7,412,830 -65% Perceptive Advisors LLC 30 Jun 2025
APLT Applied Therapeutics, Inc. Common Stock, $0.0001 par value per share 2.4% $1,115,400 2,860,000 Perceptive Advisors LLC 31 Dec 2024
SRZN Surrozen, Inc. Common Stock, $0.0001 par value per share 1.9% $1,669,993 166,666 0% Perceptive Advisors LLC 31 Mar 2025
VRCA Verrica Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 1.6% $725,926 -$1,592,338 1,481,481 -69% Perceptive Advisors LLC 31 Mar 2025
ATXS Astria Therapeutics, Inc. Common Stock, par value $0.001 per share 0% $0 -$82,494,542 0 -100% Perceptive Advisors LLC 26 Jan 2026
ACRV Acrivon Therapeutics, Inc. Common Stock, par value $0.001 per share 0% $0 -$3,600,801 0 -100% Perceptive Advisors LLC 02 Jun 2025
TIL Instil Bio, Inc. Common Stock, par value $0.000001 per share 0% $0 0 Perceptive Advisors LLC 31 Mar 2025
VRNA Verona Pharma plc Ordinary shares, nominal value GBP 0.05 per share 0% $0 -$587,715,036 0 -100% Perceptive Advisors LLC 30 Sep 2025
LYRA Lyra Therapeutics, Inc. Common Stock, $0.001 par value 0% $0 -$595,704 0 -100% Perceptive Advisors LLC 21 Nov 2025
KALA KALA BIO, Inc. Common Stock, par value $0.001 per share 0% $0 -$831,712 0 -100% Perceptive Advisors LLC 30 Sep 2025
OKUR OnKure Therapeutics, Inc. Common Stock, par value $0.0001 per share $0 0 Perceptive Advisors LLC 30 Jun 2025

Schedules 13D/G Reported by PERCEPTIVE ADVISORS LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .